Literature DB >> 31813253

Evaluation of the associations between circulating microRNAs and kidney function in coronary angiography patients.

Axel Muendlein1, Kathrin Geiger1, Andreas Leiherer1,2,3, Christoph H Saely1,3,4, Peter Fraunberger2, Heinz Drexel1,3,5,6.   

Abstract

Circulating microRNAs (miRNAs) have been linked to chronic kidney disease. Little is known about the association between circulating miRNAs and kidney function in patients at high cardiovascular risk. We therefore investigated the association between a panel of candidate miRNAs and kidney function, based on estimated glomerular filtration rate (eGFR), in two independent cohorts of patients undergoing coronary angiography. The present study totally included 438 patients undergoing coronary angiography, who were divided into a discovery cohort (n = 120) and a validation cohort (n = 318). A candidate miRNA panel comprising 50 renal miRNAs was selected from the literature, and expression levels of circulating miRNAs were determined by real-time PCR. Out of the initially tested candidate miRNAs, 38 miRNAs were sufficiently detectable in plasma. Their association with kidney function was evaluated in the discovery cohort. Associations of seven of these miRNAs with eGFR were significant after multiple testing correction via false discovery rate estimation. To verify obtained results, miRNAs with significant false discovery rates were further analyzed in the validation cohort. miR-106b-5p, miR-16-5p, miR-19b-3p, miR-20a-5p, miR-25-3p, and miR-451a proved to be significantly associated with eGFR also in the validation cohort (all P < 0.001). Association between the identified renal miRNAs and kidney function was confirmed by analysis of covariance adjusting for age, sex, type 2 diabetes, hypertension, and albumin-to-creatinine ratio. In conclusion, our study showed that miR-16-5p, miR-19b-3p, miR-20a-5p, miR-25-3p, miR-106b-5p, and miR-451a are significantly linked to kidney function in patients undergoing coronary angiography.

Entities:  

Keywords:  biomarker; coronary angiography; estimated glomerular filtration rate; microRNA

Year:  2019        PMID: 31813253     DOI: 10.1152/ajprenal.00429.2019

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  5 in total

1.  Plasma circulating microRNAs in patients with stable coronary artery disease - Impact of different cardiovascular risk profiles and glomerular filtration rates.

Authors:  Karlis Trusinskis; Maris Lapsovs; Sandra Paeglite; Evija Knoka; Laima Caunite; Mairita Mazule; Ieva Briede; Sanda Jegere; Indulis Kumsars; Inga Narbute; Ilze Konrade; Andrejs Erglis; Aivars Lejnieks
Journal:  J Clin Transl Res       Date:  2021-04-16

2.  CircUSP36 knockdown alleviates oxidized low‑density lipoprotein‑induced cell injury and inflammatory responses in human umbilical vein endothelial cells via the miR‑20a‑5p/ROCK2 axis.

Authors:  Jun Miao; Bo Wang; Ran Shao; Yan Wang
Journal:  Int J Mol Med       Date:  2021-02-12       Impact factor: 4.101

3.  PTGER3 and MMP-2 play potential roles in diabetic nephropathy via competing endogenous RNA mechanisms.

Authors:  Yue Yu; Yuan-Yuan Jia; Meng Wang; Lin Mu; Hong-Jun Li
Journal:  BMC Nephrol       Date:  2021-01-12       Impact factor: 2.388

4.  Depleted HDAC3 attenuates hyperuricemia-induced renal interstitial fibrosis via miR-19b-3p/SF3B3 axis.

Authors:  Langtao Hu; Kai Yang; Xing Mai; Jiali Wei; Chunyang Ma
Journal:  Cell Cycle       Date:  2022-01-13       Impact factor: 5.173

5.  Antagonist targeting miR‑106b‑5p attenuates acute renal injury by regulating renal function, apoptosis and autophagy via the upregulation of TCF4.

Authors:  Jing-Meng Hu; Li-Jie He; Peng-Bo Wang; Yan Yu; Ya-Ping Ye; Li Liang
Journal:  Int J Mol Med       Date:  2021-07-19       Impact factor: 4.101

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.